Antimicrobial agent, a derivative of nitrofuran.
Effective against gram-positive cocci (Staphylococcus spp., Streptococcus spp.), Gram-negative rods (E. coli, Salmonella spp., Shigella spp., Klebsiella spp.). Stable Plasmodium aeruginosa, Enterococcus spp., Acinetobacter spp., most strains Proteus spp., Serratia spp.
The mechanism of action is related to the inhibition of the synthesis of nucleic acids. Depending on the concentration has a bactericidal or bacteriostatic effect.
Against most bacteria, the bacteriostatic concentration ranges from 10-20 μg / ml. The bactericidal concentration is approximately 2 times higher. Under the influence of nitrofurans in microorganisms, the activity of the respiratory chain and the cycle of tricarboxylic acids (Krebs cycle) is suppressed, as well as the inhibition of other biochemical processes, which leads to the destruction of their membrane or cytoplasmic membrane. As a result of the action of nitrofurans, microorganisms produce less toxins, in connection with which the improvement of the general state of the patient is possible even before the expressed suppression of microflora growth. Nitrofurans unlike many other antimicrobial medicines not only do not depress the immune system of the body, but, on the contrary, activate it (increase the complement titre and the ability of leukocytes to phagocytose microorganisms).